MONOPAR THERAPEUTICS INC
MNPR·61023L207·US·Common Stock·Healthcare - Biotechnology-Activist
MNPR (MONOPAR THERAPEUTICS INC) is held by 57 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($72.1M), RA CAPITAL MANAGEMENT, L.P. ($36.6M), BlackRock, Inc. ($17.3M). Net institutional sentiment: Mixed.
57
Holders
Avg rating(11 Elite)
$245M
Total Value
64% (63)
Fund Consensus
36 buying - 20 selling
Who's Trading
ActivistSVSaturn V Capital Management LP5.2%May 15, 2026
ActivistADAdage Capital Management, L.P.6.2%May 13, 2026
ActivistAPAstraZeneca PLC7.8%Feb 6, 2026
ActivistTPTactic Pharma LLC0.0%Jan 30, 2026
InsiderVAVu Quan AnhBuy $105KDec 26, 2025
InsiderKJKLAUSNER ARTHUR JSell $312KDec 18, 2025
InsiderKJKLAUSNER ARTHUR JSell $31KDec 18, 2025
InsiderTLTactic Pharma LLCSell $35.0MSep 24, 2025
13F: Insider & Congress:
Showing 1-20 of 63
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer